MTD - Mettler-Toledo International Inc.
NEXT EARNINGS:
May 7, 2026
EPS Est: $8.78
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$1485.00
DETAILS
HIGH:
$1600.00
LOW:
$1400.00
MEDIAN:
$1475.00
CONSENSUS:
$1485.00
UPSIDE:
7.64%
Market Cap:
28.18B
Volume:
111,073
Avg Volume:
149,363
52 Week Range:
946.69-1525.17
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.44
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
16,000
IPO Date:
1997-11-14
EPS (TTM):
42.17
P/E Ratio:
33.06
Revenue (TTM):
4.03B
Total Assets:
3.71B
Total Debt:
2.34B
Cash & Equiv:
66.89M
Rev Growth (5Y):
5.5%
EPS Growth (5Y):
10.8%
FCF Growth (5Y):
6.1%
ROCE:
44.1%
Debt/Equity:
-99.14
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $13.36 | $12.76 | +4.7% | $1.1B | $939.2M | +20.3% |
| 2025-11-06 | $11.15 | $10.66 | +4.6% | $1.0B | $997.3M | +3.3% |
| 2025-07-31 | $10.09 | $9.60 | +5.1% | $983.2M | $957.6M | +2.7% |
| 2025-05-01 | $8.19 | $7.88 | +3.9% | $883.7M | $876.6M | +0.8% |
| 2025-02-06 | $12.41 | $11.72 | +5.9% | $1.0B | $1.0B | +3.6% |
| 2024-11-08 | $10.21 | $10.01 | +2.0% | $954.5M | $944.8M | +1.0% |
| 2024-08-01 | $9.65 | $9.03 | +6.9% | $946.8M | $929.1M | +1.9% |
| 2024-05-09 | $8.89 | $7.64 | +16.4% | $925.9M | $879.7M | +5.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.03B | 3.87B | 3.79B | 3.92B | 3.72B | 3.09B | 3.01B | 2.94B | 2.73B | 2.51B | 2.40B | 2.49B |
| Net Income | 869.19M | 863.14M | 788.78M | 872.50M | 768.99M | 602.74M | 561.11M | 512.61M | 375.97M | 384.37M | 352.82M | 338.24M |
| EPS | 42.17 | 40.67 | 36.10 | 38.79 | 33.25 | 25.24 | 22.84 | 20.33 | 14.62 | 14.49 | 12.75 | 11.71 |
| Total Assets | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B | 2.81B | 2.79B | 2.62B | 2.55B | 2.17B | 1.96B | 2.01B |
| Total Debt | 2.34B | 2.13B | 2.20B | 2.13B | 1.80B | 1.33B | 1.29B | 1.03B | 979.85M | 894.03M | 589.63M | 451.95M |
| Cash & Equivalents | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M | 94.25M | 207.78M | 178.11M | 148.69M | 158.67M | 98.89M | 85.26M |
| Operating Cash Flow | 955.77M | 968.35M | 965.87M | 859.07M | 908.83M | 724.70M | 603.45M | 565.00M | 516.33M | 443.08M | 426.87M | 418.91M |
| Free Cash Flow | 848.65M | 864.45M | 860.55M | 737.83M | 801.25M | 632.21M | 506.11M | 422.28M | 388.90M | 319.12M | 344.36M | 329.52M |
| FCF per Share | 41.18 | 40.73 | 39.39 | 32.80 | 34.64 | 26.47 | 20.60 | 16.75 | 15.12 | 12.03 | 12.44 | 11.41 |
| Book Value | (23.64M) | (126.89M) | (149.94M) | 24.79M | 171.42M | 282.68M | 420.78M | 590.06M | 547.28M | 434.94M | 580.46M | 719.60M |
| Cash & ST Investments | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M | 94.25M | 207.78M | 178.11M | 148.69M | 158.67M | 98.89M | 85.26M |
| ROC Equity | N/A | N/A | N/A | 35.19 | 4.49 | 2.13 | 1.33 | 0.87 | 0.69 | 0.88 | 0.61 | 0.47 |